CRTAC1 and telomere syndrome: The commercial ELISA kit used may not be suitable for serum CRTAC1 quantification, as many samples had CRTAC1 levels below the minimum detectable concentration (1.23 ng·mL−1): control group = 41.7%, STS group = 66.7%, and LTS group = 61.5%.